<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>GBIHealth | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-12-01T09:53:32+08:00</updated>
  <subtitle>GBI专注于中国市场，为药企、器械企业和其他服务提供商建立多元的市场情报解决方案组合。GBI的高附加值行业信息、新闻和数据服务能力帮助个人和组织做出以数据为驱动的决策，更高效地沟通。</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>叮！20款药 上海黄线警告</title>
    <updated>2020-11-30T23:00:39+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-30:/s/Xvtb5TFcG0q8oqg1334b3A</id>
    <link href="https://mp.weixin.qq.com/s/Xvtb5TFcG0q8oqg1334b3A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>撤销药店开办设定的间距限制；首个治疗特定基因缺陷引起的肥胖症新药获FDA批准；渤健达成研发合作开发突破性抑郁症和运动障碍疗法</title>
    <updated>2020-11-30T23:00:39+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-30:/s/6_8WBER2qHAJJseOkT0a1A</id>
    <link href="https://mp.weixin.qq.com/s/6_8WBER2qHAJJseOkT0a1A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>DEVINT | 上海凯利泰金属锁定接骨板钉系统产品获菲律宾注册证；心脏介入器械企业科凯生命科学完成数亿元B轮融资</title>
    <updated>2020-11-30T23:00:39+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-30:/s/MymbBRFypJAXhofmzsneJQ</id>
    <link href="https://mp.weixin.qq.com/s/MymbBRFypJAXhofmzsneJQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>GBI英文期刊 | 专利悬崖进入中国？专利管理寻求新的利益平衡模式</title>
    <updated>2020-11-29T21:14:03+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-29:/s/Z5ZzhpS1RhHTfPn8F3D2fQ</id>
    <link href="https://mp.weixin.qq.com/s/Z5ZzhpS1RhHTfPn8F3D2fQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>默沙东抗艾滋病药获批；修美乐全球首次获批新适应症；拜耳首创新药获III期临床最新数据；IDT中国成立，深耕基因组学和核酸产品</title>
    <updated>2020-11-29T21:14:03+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-29:/s/UAV1TT2gf7zu9GtKPl9OCQ</id>
    <link href="https://mp.weixin.qq.com/s/UAV1TT2gf7zu9GtKPl9OCQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>DEVINT | 药监局发布新通告规范并指导医疗器械上市后风险评价；三代试管PGS检测正式进入“有证”时代</title>
    <updated>2020-11-29T21:14:03+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-29:/s/pquiVwZ-7Yjs8_DkU01QSA</id>
    <link href="https://mp.weixin.qq.com/s/pquiVwZ-7Yjs8_DkU01QSA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>默沙东提交15价肺炎疫苗上市申请；罗氏流感新药获批准新适应症；诺和诺德长效胰岛素在中国获批临床；复星2大进展...</title>
    <updated>2020-11-26T17:23:46+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-26:/s/4PecClImuRyxVkmbbYysow</id>
    <link href="https://mp.weixin.qq.com/s/4PecClImuRyxVkmbbYysow" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>DEVINT | 粤港澳大湾区或打造第二个“乐城先行区”；国家药监局发布《真实世界数据用于医疗器械临床评价技术指导原则（试行）》</title>
    <updated>2020-11-26T17:23:46+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-26:/s/VyAaFvf2aiiXEOoKYzSgtg</id>
    <link href="https://mp.weixin.qq.com/s/VyAaFvf2aiiXEOoKYzSgtg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>就在今天！| 创新重构产业：一场200人和2000人的对话！</title>
    <updated>2020-11-26T17:23:46+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-26:/s/_oC2KOwYS4MDBOSfR7jMqg</id>
    <link href="https://mp.weixin.qq.com/s/_oC2KOwYS4MDBOSfR7jMqg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>带量采购 | 山东大汉，一降到底；湖南辣妹，死磕注射剂；高值耗材，第二波儿来袭！</title>
    <updated>2020-11-25T19:44:22+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-25:/s/jXumSqVmi_Mko-e9Wq_QXg</id>
    <link href="https://mp.weixin.qq.com/s/jXumSqVmi_Mko-e9Wq_QXg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>默沙东达成4.25亿美元现金交易；礼来BTK抑制剂获批临床；石药首创在研药获FDA孤儿药资格认定</title>
    <updated>2020-11-25T19:44:22+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-25:/s/8ZO0orr6jDC1Q4NdzDmuLg</id>
    <link href="https://mp.weixin.qq.com/s/8ZO0orr6jDC1Q4NdzDmuLg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>礼来巴瑞替尼获FDA紧急使用授权；诺华奥法妥木单抗进入优先审评；恒瑞两款新药拟纳入突破性治疗品种；武田安吉优获批上市</title>
    <updated>2020-11-24T22:38:01+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-24:/s/uEo-PpXtVvkMsRgDjmCQ8w</id>
    <link href="https://mp.weixin.qq.com/s/uEo-PpXtVvkMsRgDjmCQ8w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>新药研发，如何定位生物药靶点才能又快又准？</title>
    <updated>2020-11-24T22:38:01+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-24:/s/Y6FQfR_y1rcEXBfI5WZu5A</id>
    <link href="https://mp.weixin.qq.com/s/Y6FQfR_y1rcEXBfI5WZu5A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>医保局发布医药价格和招采信用评价；BMS一线药拟纳入优先审评；再生元抗体药获FDA紧急使用授权；诺华与Mesoblast达成合作</title>
    <updated>2020-11-23T18:18:17+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-23:/s/2W68SipZxFoGjdk_uH5IOg</id>
    <link href="https://mp.weixin.qq.com/s/2W68SipZxFoGjdk_uH5IOg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>DEVINT | 武田血友病管理工具myPKFiT获批；FDA批准首个家用新冠试剂盒</title>
    <updated>2020-11-23T18:18:17+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-23:/s/l-u8gEF_Dyqe0cjZH1rlcQ</id>
    <link href="https://mp.weixin.qq.com/s/l-u8gEF_Dyqe0cjZH1rlcQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>议程公开 | 2020第三届中国生物医药创新合作大会</title>
    <updated>2020-11-23T18:18:17+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-23:/s/Gxyc3R9zbYrWzOVsa4o55Q</id>
    <link href="https://mp.weixin.qq.com/s/Gxyc3R9zbYrWzOVsa4o55Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>会议精选 | 第九届中国医药决策科学峰会暨CphMRA 2020年度会议</title>
    <updated>2020-11-22T17:54:39+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-22:/s/1QBpOnxMSS8KkZHfE3KjEg</id>
    <link href="https://mp.weixin.qq.com/s/1QBpOnxMSS8KkZHfE3KjEg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>国家药监局药审中心发布重磅政策；第三款RNAi药物获欧盟批准；首个早衰症治疗药物获FDA批准；先声药业引进的1类新药获批临床</title>
    <updated>2020-11-22T17:54:39+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-22:/s/rCFIgpFQk9KO_ghIT36jYA</id>
    <link href="https://mp.weixin.qq.com/s/rCFIgpFQk9KO_ghIT36jYA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>县域医药市场发展及影响因素</title>
    <updated>2020-11-22T17:54:39+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-22:/s/636kEs6XC5cGJHBnW9gPXQ</id>
    <link href="https://mp.weixin.qq.com/s/636kEs6XC5cGJHBnW9gPXQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>最落地的数据产能创新 | 从快消产业到医疗健康 资源极端紧缩下的生存方式</title>
    <updated>2020-11-20T01:37:31+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-20:/s/IXSbLWA6K8_o8hu3xURkZA</id>
    <link href="https://mp.weixin.qq.com/s/IXSbLWA6K8_o8hu3xURkZA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>